To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers
Clinical trial NCT05259020 · UNKNOWN
Trial details
- NCT number
- NCT05259020
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2022-03-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.